2017•Journal of Thoracic DiseaseOpen access

Primary prevention implantable cardioverter defibrillator in patients with reduced ejection fraction: for ischemic or non-ischemic cardiomyopathy or both?

Amr F. Barakat, Mahmoud Ahmed, Islam Y. Elgendy

Abstract

The European Society of Cardiology (ESC) and the American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend implantable cardioverter-defibrillator (ICD) for primary prevention of sudden cardiac death in patients with heart failure and reduced left ventricular ejection fraction (1,2).

Open-access reader

About this research paper

What this paper is about

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Cardiology, Implantable cardioverter-defibrillator, Ejection fraction, Internal medicine, Ischemic cardiomyopathy, Primary prevention, Sudden cardiac death